Skip to main content
OpenTrials
Completed

NCT Number: NCT05237778

Combined Treatment of Nightmares With Targeted Memory Reactivation and Imagery Rehearsal Therapy

With this protocol, investigators examine whether targeted memory reactivation (TMR), a technique used to strengthen memories, can accelerate remission of nightmare disorder. This protocol uses TMR during REM sleep to strengthen positive memories generated by Imagery Rehearsal Therapy (IRT), a recommended treatment of nightmares. Patients with nightmare disorder are asked to perform an initial IRT session and, while they generate a positive outcome of their recurrent nightmare, half of the patients are exposed to a sound (TMR group), while no such pairing with a sound takes place for the other half (control group). During the next two weeks, all patients perform IRT every evening at home and are exposed to the sound during REM sleep with a wireless headband, which automatically detects sleep stages. Clinical evaluation of the severity of nightmares before and after (2-weeks follow-up and 3-months follow-up) this intervention takes place using the validated Nightmare Frequency Questionnaire (NFQ, primary outcome measure), which retrospectively identifies the frequency of nightmares. We hypothesize that patients treated with IRT and who are exposed, during REM sleep and over 14 nights, to a sound that had previously been associated with the new positive dream scenario of IRT (TMR group), will have more reduced frequency of nightmares compared to participants with stimulation of the same, but non-associated, sound during REM sleep (control group).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Center for Sleep Medicine, University Hospitals of Geneva

Geneva, 1225, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of nightmare disorder according to the International Classification of Sleep Disorders (ICSD-3) diagnostic and coding manual
  • Patients with at least moderate severity (>1 episode per week)

Exclusion criteria

  • severe depression
  • insomnia disorder
  • psychosis or anxiety disorder
  • other sleep disorder (e.g.,obstructive sleep apnea syndrome, restless legs syndrome)
  • neurological disease
  • use of medications that would be likely to produce nightmares (e.g. hypnotics, β-blockers, amphetamines, antimicrobial agents)
  • use of anxiolytics, antipsychotic or antidepressant medication were excluded.

Treatment and study plan

Imagery Rehearsal Therapy and Targeted memory reactivation during REM sleep

Behavioral

Emerging evidence shows that REM sleep plays a causal role in extinction learning, emotion regulation and consolidation of emotionally positive memories. By using targeted memory reactivation (TMR), a known method where we associate a sound with a waking experience (i.e., a positive outcome of imagery rehearsal therapy in this study) and strengthening it during REM sleep, we want to accelerate the remission of nightmares.

Imagery Rehearsal Therapy

Behavioral

These patients will receive the classic treatment of Imagery Rehearsal Therapy (IRT) for nightmares without any association with a sound.

Primary outcomes

  1. Nightmare Frequency Questionnaire (NFQ)

    Time frame: 2 weeks

    Validated self-report scale to assess the number of nightmares per week

  2. Nightmare Frequency Questionnaire (NFQ)

    Time frame: 3 months

    Validated self-report scale to assess the number of nightmares per week

Secondary outcomes

  1. Nightmare Distress Questionnaire (NDQ)

    Time frame: 2 weeks

    Validated self-report scale to assess the emotional disturbance attributed to the nightmares

  2. Beck Depression Inventory (BDI-II)

    Time frame: 2 weeks

    Validated self-report scale to assess depressive symptoms

  3. Pittsburgh Sleep Quality Index (PSQI)

    Time frame: 2 weeks

    Validated self-report scale to assess the quality of sleep

  4. Proportion of the emotion 'joy' in dreams

    Time frame: 2 weeks

    Use of a dream diary

  5. Proportion of the emotion 'fear' in dreams

    Time frame: 2 weeks

    Use of a dream diary

  6. Nightmare Distress Questionnaire (NDQ)

    Time frame: 3 months

    Validated self-report scale to assess the emotional disturbance attributed to the nightmares

  7. Beck Depression Inventory (BDI-II)

    Time frame: 3 months

    Validated self-report scale to assess depressive symptoms

  8. Pittsburgh Sleep Quality Index (PSQI)

    Time frame: 3 months

    Validated self-report scale to assess the quality of sleep

Sponsors and collaborators

Lead sponsor

University Hospital, Geneva

Other

Registry information

Official study title

The Nightmare Catcher: Modulating Dreams With Targeted Memory Reactivation

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Feb 14, 2022
Registry last updated
Feb 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.